import type { Metadata } from 'next';
import Link from 'next/link';

export const metadata: Metadata = {
  title: 'Rhodiola Rosea Drug Interactions: MAOIs, Stimulants, and What NCCIH Documents',
  description:
    'Rhodiola rosea has mild MAO-inhibiting properties and stimulant-like effects on dopaminergic and noradrenergic systems. Combined with prescription MAOIs or stimulant medications, these effects may be additive.',
  openGraph: {
    title: 'Rhodiola Rosea Drug Interactions: MAOIs, Stimulants, and What NCCIH Documents',
    description:
      'Rhodiola acts as an adaptogen with stimulant properties and mild MAO-inhibiting activity. What this means when combined with antidepressants or stimulant medications.',
    type: 'article',
    publishedTime: '2026-07-12',
  },
  alternates: {
    canonical: "https://stackverify.app/blog/rhodiola-drug-interactions",
  },
};

export default function RhodiolaDrugInteractions() {
  return (
    <main className="max-w-2xl mx-auto px-4 py-12 sm:py-16">
      <script
        type="application/ld+json"
        dangerouslySetInnerHTML={{
          __html: JSON.stringify({
            "@context": "https://schema.org",
            "@type": "Article",
            "headline": "Rhodiola Rosea Drug Interactions: MAOIs, Stimulants, and What NCCIH Documents",
            "datePublished": "2026-07-12",
            "publisher": {
              "@type": "Organization",
              "name": "StackVerify"
            }
          })
        }}
      />
      <nav className="text-sm text-zinc-400 mb-8">
        <Link href="/blog" className="hover:text-zinc-600 transition-colors">
          ← Blog
        </Link>
      </nav>

      <div className="mb-2 text-xs text-zinc-400">2026-07-12</div>
      <h1 className="text-2xl font-semibold text-zinc-900 tracking-tight leading-tight">
        Rhodiola Rosea Drug Interactions: MAOIs, Stimulants, and What NCCIH Documents
      </h1>

      <div className="mt-4 p-3 bg-amber-50 border border-amber-200 rounded-lg text-sm text-amber-800">
        <strong>Not medical advice.</strong> This article is for informational purposes only.
        Consult a doctor or pharmacist before making any decisions about your medications or
        supplements.
      </div>

      <div className="mt-8 space-y-6 text-zinc-700 leading-relaxed">
        <p>
          Rhodiola rosea is an adaptogenic herb used primarily for fatigue, stress, and cognitive
          performance. It has a longer and better-characterized safety record than many supplements
          in this category, but that doesn't mean it's interaction-free. Two areas warrant specific
          attention: its mild monoamine oxidase (MAO) inhibiting properties, which create a
          theoretical interaction with prescription antidepressants in the MAOI class, and its
          stimulant-like effect on dopamine and norepinephrine systems, which may be additive with
          stimulant medications. Understanding these mechanisms helps clarify which combinations
          to approach cautiously.
        </p>

        <section>
          <h2 className="text-lg font-semibold text-zinc-900 mt-8 mb-3">
            MAO inhibition: the antidepressant interaction
          </h2>
          <p>
            Monoamine oxidase is the enzyme responsible for breaking down serotonin, dopamine, and
            norepinephrine in the brain and elsewhere. Prescription MAOIs — phenelzine (Nardil),
            tranylcypromine (Parnate), isocarboxazid (Marplan) — block this enzyme, allowing
            monoamines to accumulate. This is their therapeutic mechanism for treatment-resistant
            depression, but it also means that anything else with MAO-inhibiting activity adds to
            that effect.
          </p>
          <p className="mt-3">
            Rhodiola extracts, particularly the compounds salidroside and the rosavins, have shown
            mild MAO-inhibiting activity in preclinical research. Whether this translates to
            clinically meaningful MAO inhibition in humans at typical supplemental doses is not
            established — the effect is substantially weaker than prescription MAOIs. But the
            combination with prescription MAOIs is still worth flagging: stacking a supplement with
            even mild MAO-inhibiting properties on top of a drug that already maximally suppresses
            MAO creates theoretical risk for excess monoamine accumulation, including serotonin.
          </p>
          <p className="mt-3">
            Selective MAO-B inhibitors used in Parkinson's disease — selegiline (Emsam) and
            rasagiline (Azilect) — also carry this consideration, particularly because at higher
            doses they lose selectivity and begin inhibiting MAO-A as well, which governs serotonin
            metabolism. Linezolid, an antibiotic used for serious drug-resistant infections, has
            MAOI properties and the same concern applies despite its non-psychiatric indication.
            NCCIH notes that rhodiola may interact with drugs that affect monoamine oxidase systems.
          </p>
          <p className="mt-3">
            The practical takeaway is not that rhodiola is dangerous for most people — it isn't —
            but that the specific combination with a prescription MAOI should prompt a conversation
            with the prescribing physician before proceeding.
          </p>
        </section>

        <section>
          <h2 className="text-lg font-semibold text-zinc-900 mt-8 mb-3">
            Stimulant properties and additive cardiovascular effects
          </h2>
          <p>
            Rhodiola's adaptogenic effects appear to involve dopaminergic and noradrenergic
            neurotransmission — the same systems that prescription stimulants target more
            aggressively. This is part of why rhodiola is used for energy and cognitive performance:
            it increases monoamine availability through mechanisms distinct from reuptake inhibition
            but with overlapping outcomes.
          </p>
          <p className="mt-3">
            Combined with prescription stimulants — methylphenidate (Ritalin, Concerta),
            amphetamines (Adderall, Vyvanse), modafinil (Provigil), or phentermine — the additive
            stimulation on dopamine and norepinephrine pathways may amplify cardiovascular effects:
            elevated heart rate, higher blood pressure, and in some cases increased anxiety or
            worsened insomnia. The effect is not equivalent to taking two doses of the stimulant —
            rhodiola's mechanism is indirect and adaptogenic — but for people who are already
            sensitive to cardiovascular side effects from their stimulant medication, adding
            rhodiola is not neutral.
          </p>
          <p className="mt-3">
            High caffeine intake compounds this further. Many people using rhodiola for performance
            or cognitive enhancement are already using substantial caffeine. Triple stacking
            caffeine, a prescription stimulant, and rhodiola pushes on all the same systems, and
            the combined effect on heart rate and blood pressure deserves attention. NCCIH
            recommends caution when combining rhodiola with stimulant medications.
          </p>
        </section>

        <section>
          <h2 className="text-lg font-semibold text-zinc-900 mt-8 mb-3">
            Blood pressure and diabetes context
          </h2>
          <p>
            Rhodiola has been studied for effects on stress-related cardiovascular parameters.
            Some research suggests it may modestly lower blood pressure in people with mild
            hypertension, which is relevant for anyone already on antihypertensive therapy — the
            additive hypotensive effect could produce symptomatic drops in blood pressure,
            particularly on standing (orthostatic hypotension). This interaction is less
            well-characterized than the MAO and stimulant interactions, but worth noting for
            people managing blood pressure with medication.
          </p>
          <p className="mt-3">
            There is also preliminary evidence that rhodiola may have mild effects on glucose
            metabolism, though this is much less established than the MAO and stimulant interaction
            data. People managing blood sugar with medications should monitor for any unexpected
            changes if adding rhodiola.
          </p>
        </section>
      </div>

      <div className="mt-10 border-t border-zinc-100 pt-6">
        <h3 className="text-sm font-semibold text-zinc-700 mb-3">Related</h3>
        <ul className="space-y-1 text-sm">
          <li><Link href="/blog/berberine-and-metformin" className="underline hover:text-zinc-900">Berberine and Metformin Together: Additive Blood Sugar Effects</Link></li>
          <li><Link href="/blog/ashwagandha-drug-interactions" className="underline hover:text-zinc-900">Ashwagandha Drug Interactions: Thyroid Medications, Immunosuppressants</Link></li>
        </ul>
      </div>

      <div className="mt-10 p-4 bg-zinc-50 border border-zinc-200 rounded-lg text-sm text-zinc-600">
        <strong className="text-zinc-800">Check your stack:</strong> Enter rhodiola alongside
        selegiline, phenelzine, Adderall, or Ritalin in the{' '}
        <Link href="/" className="underline hover:text-zinc-800">
          StackVerify checker
        </Link>{' '}
        to see these interactions flagged.
      </div>

      <div className="mt-6 text-xs text-zinc-400">
        Source:{' '}
        <a
          href="https://www.nccih.nih.gov/health/rhodiola"
          target="_blank"
          rel="noopener noreferrer"
          className="underline hover:text-zinc-600"
        >
          NCCIH — Rhodiola
        </a>
      </div>
    </main>
  );
}
